tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market
JAZZ
Jazz Pharmaceuticals
RESEARCH TOOLSreports
Want to see JAZZ full AI Analyst Report?

Jazz Pharmaceuticals (JAZZ) Ratios

1,893 Followers

Jazz Pharmaceuticals Ratios

JAZZ's free cash flow for Q1 2026 was $0.71. For the 2026 fiscal year, JAZZ's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.04 1.86 4.46 2.24 2.79
Quick Ratio
 1.85 1.67 3.99 1.85 2.03
Cash Ratio
 0.82 0.62 2.32 0.98 0.94
Solvency Ratio
 0.08 0.03 0.15 0.14 0.05
Operating Cash Flow Ratio
 0.59 0.60 1.34 0.71 1.36
Short-Term Operating Cash Flow Coverage
 1.29 1.32 45.03 1.81 41.03
Net Current Asset Value
$ -2.74B$ -3.17B$ -3.29B$ -4.22B$ -5.14B
Leverage Ratios
Debt-to-Assets Ratio
 0.46 0.47 0.51 0.51 0.54
Debt-to-Equity Ratio
 1.20 1.26 1.51 1.55 1.88
Debt-to-Capital Ratio
 0.54 0.56 0.60 0.61 0.65
Long-Term Debt-to-Capital Ratio
 0.49 0.50 0.60 0.58 0.65
Financial Leverage Ratio
 2.62 2.70 2.93 3.05 3.51
Debt Service Coverage Ratio
 0.52 0.31 5.99 1.75 5.10
Interest Coverage Ratio
 2.41 1.15 3.01 2.00 -0.23
Debt to Market Cap
 0.36 0.52 0.80 0.73 0.57
Interest Debt Per Share
 90.82 92.14 103.50 96.08 97.54
Net Debt to EBITDA
 9.03 37.17 2.46 2.96 3.36
Profitability Margins
Gross Profit Margin
84.12%88.21%89.05%88.64%85.23%
EBIT Margin
-3.67%-10.16%21.18%21.14%22.93%
EBITDA Margin
8.91%2.54%37.40%37.80%40.13%
Operating Profit Margin
11.13%5.26%17.61%15.09%-1.79%
Pretax Profit Margin
-4.93%-14.73%11.52%7.69%-10.46%
Net Profit Margin
0.66%-8.35%13.77%10.82%-6.12%
Continuous Operations Profit Margin
0.66%-8.35%13.77%10.82%-6.12%
Net Income Per EBT
-13.46%56.66%119.51%140.66%58.55%
EBT Per EBIT
-44.33%-280.09%65.40%50.97%584.03%
Return on Assets (ROA)
0.25%-3.05%4.66%3.64%-2.07%
Return on Equity (ROE)
0.71%-8.25%13.68%11.10%-7.26%
Return on Capital Employed (ROCE)
5.14%2.38%6.53%5.87%-0.66%
Return on Invested Capital (ROIC)
-0.62%1.22%6.50%5.52%-0.39%
Return on Tangible Assets
0.50%-6.59%10.11%9.83%-6.69%
Earnings Yield
0.20%-3.44%7.36%5.33%-2.25%
Efficiency Ratios
Receivables Turnover
 5.31 5.14 5.68 5.43 5.62
Payables Turnover
 7.05 4.12 5.72 4.24 5.96
Inventory Turnover
 1.61 1.21 0.93 0.73 0.76
Fixed Asset Turnover
 17.14 16.49 17.93 16.32 12.14
Asset Turnover
 0.37 0.37 0.34 0.34 0.34
Working Capital Turnover Ratio
 2.08 1.55 1.48 2.15 2.11
Cash Conversion Cycle
 243.49 284.92 393.97 481.39 485.89
Days of Sales Outstanding
 68.77 71.05 64.30 67.19 64.98
Days of Inventory Outstanding
 226.48 302.39 393.44 500.30 482.19
Days of Payables Outstanding
 51.77 88.52 63.77 86.10 61.29
Operating Cycle
 295.25 373.44 457.74 567.49 547.17
Cash Flow Ratios
Operating Cash Flow Per Share
 21.55 22.23 22.57 17.25 20.34
Free Cash Flow Per Share
 20.12 21.27 21.80 16.88 12.37
CapEx Per Share
 1.43 0.96 0.78 0.38 7.97
Free Cash Flow to Operating Cash Flow
 0.93 0.96 0.97 0.98 0.61
Dividend Paid and CapEx Coverage Ratio
 15.06 23.08 29.04 45.57 2.55
Capital Expenditure Coverage Ratio
 15.06 23.08 29.04 45.57 2.55
Operating Cash Flow Coverage Ratio
 0.25 0.25 0.23 0.19 0.22
Operating Cash Flow to Sales Ratio
 0.30 0.32 0.34 0.28 0.35
Free Cash Flow Yield
8.39%12.51%17.70%13.72%7.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 500.71 -29.11 13.60 18.77 -44.47
Price-to-Sales (P/S) Ratio
 3.37 2.43 1.87 2.03 2.72
Price-to-Book (P/B) Ratio
 3.26 2.40 1.86 2.08 3.23
Price-to-Free Cash Flow (P/FCF) Ratio
 12.02 7.99 5.65 7.29 12.88
Price-to-Operating Cash Flow Ratio
 11.07 7.65 5.46 7.13 7.83
Price-to-Earnings Growth (PEG) Ratio
 -1.69 0.18 0.35 -0.07 1.27
Price-to-Fair Value
 3.26 2.40 1.86 2.08 3.23
Enterprise Value Multiple
 46.89 132.76 7.47 8.33 10.14
Enterprise Value
 18.41B 14.40B 11.36B 12.07B 14.89B
EV to EBITDA
 46.56 132.76 7.47 8.33 10.14
EV to Sales
 4.15 3.37 2.79 3.15 4.07
EV to Free Cash Flow
 14.78 11.10 8.43 11.30 19.25
EV to Operating Cash Flow
 13.80 10.62 8.14 11.05 11.71
Tangible Book Value Per Share
 -23.85 -31.82 -38.46 -54.26 -70.38
Shareholders’ Equity Per Share
 73.22 70.81 66.20 59.04 49.34
Tax and Other Ratios
Effective Tax Rate
 1.13 0.43 -0.20 -0.41 0.41
Revenue Per Share
 71.71 69.98 65.80 60.58 58.51
Net Income Per Share
 0.48 -5.84 9.06 6.55 -3.58
Tax Burden
 -0.13 0.57 1.20 1.41 0.59
Interest Burden
 1.34 1.45 0.54 0.36 -0.46
Research & Development to Revenue
 0.17 0.18 0.22 0.22 0.16
SG&A to Revenue
 0.37 0.42 0.34 0.00 0.00
Stock-Based Compensation to Revenue
 0.10 0.07 0.06 0.06 0.06
Income Quality
 -1.24 -3.81 2.49 2.63 -5.68
Currency in USD